New EU guidance tells notified bodies they must wait to issue a certificate for a high-risk IVD in cases where a similar product is under review by an expert panel.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Read more about our privacy policy here.